Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 May-Jun;49(3):T169-T178.
doi: 10.1016/j.farma.2024.11.008. Epub 2024 Dec 28.

[Translated article] Drug dosing in obese critically ill patients, a literature review

[Article in English, Spanish]
Affiliations
Free article
Review

[Translated article] Drug dosing in obese critically ill patients, a literature review

[Article in English, Spanish]
Hector Carlos García-Díaz et al. Farm Hosp. 2025 May-Jun.
Free article

Abstract

Introduction: Obesity constitutes a global public health problem, and knowledge about drug dosing in obese patients is limited. Clinical trials in critically ill patients rarely include obese individuals, resulting in a lack of specific dosing information in product data sheets. The aim of this literature review is to provide clinicians with efficient and safe guidelines for this group of patients.

Methods: A multidisciplinary group composed of pharmacists specialised in hospital pharmacy and physicians specialised in intensive care medicine was formed. The therapeutic groups and, in depth, the most commonly used active ingredients in the intensive care unit were identified and reviewed. The bibliographic review was carried out using terms such as: "obese", "overweight", "critical illness", "drug dosification", and "therapeutic dose monitoring". All the information was evaluated by the working group, which reached a consensus on dosing recommendations for each drug in obese critically ill patients.

Results: Eighty three drugs belonging to the following therapeutic groups were identified: antivirals, antibacterials, antifungals, immunosuppressants, antiepileptics, vasopressors, anticoagulants, neuromuscular blocking agents, and sedatives. A table with the consensus dosing recommendation for each of these was produced after review.

Conclusions: Drug dosing in obese patients, both in critical and non-critical settings, remains an area with significant uncertainties. This review provides updated and exhaustive information on the dosing of the main therapeutic groups in obese critically ill patients, and is a useful tool for both physicians in critical care units and clinical pharmacists in their practice in this setting.

Keywords: Body weight; Critically ill; Dosificación de fármacos; Drug dosing; Enfermo crítico; Intensive care unit; Monitorización farmacocinética; Obese patient; Paciente obeso; Peso corporal; Therapeutic drug monitoring; Unidad de cuidados intensivos.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare that they have no conflicts of interest.

Substances

LinkOut - more resources